Trial Details
RECRUITINGBasic Information
| Clinical ID | c788 |
|---|---|
| Identifier | NCT06051253 |
| Trial Title | TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease|Infliximab|Perianal Fistula Due to Crohn's Disease|Therapeutic Drug Monitoring|Magnetic Resonance Novel Index for Fistula Imaging in Crohn's Disease Score |
| Interventions | DRUG: TDM-based infliximab intravenous therapy|DRUG: Standard infliximab intravenous therapy |
Participant Information
| Sponsor | Asan Medical Center |
|---|---|
| City | Seoul |
| Country/Region | South Korea |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2023-11-01 |
|---|---|
| Primary Completion Date | 2026-06-30 |
| Completion Date | 2027-06-30 |